Gundlach says not positive on long-term Treasury bonds due to ‘fiscal financing problem’
Nov. 08, 2024 2:12 PM ETUnited States 10-12 months Bond Yield (US10Y), US2YAGG, IEF, LQD, SHY, TIP, TLT, IEI, TLH, ...
Tag: positive
Trump win seen generally positive for markets
Donald Trump’s victory within the US presidential election has been anticipated by the monetary markets. Bitcoin rose by 10% ...
Tradeweb: Positive Revenue Growth Momentum Continues (TW)
This text was written byObserveI take into account an funding splendid if it performs its core enterprise in a sector ...
AT&T is now on Citi’s positive catalyst watch By Investing.com
Investing.com -- AT&T Inc. has been added to Citi’s optimistic catalyst watch checklist, with analysts expressing optimism forward of the corporate’s ...
BofA maintains positive stance on Corteva stock, anticipating continued success driven by recent tailwinds By Investing.com
On Wednesday, BofA Securities issued an improve for Corteva Inc. (NYSE:), shifting its ranking from Impartial to Purchase and growing ...
Abercrombie & Fitch added to JPMorgan’s Positive Catalyst Watch, shares edge up By Investing.com
Investing.com -- Shares in Abercrombie & Fitch (NYSE:) edged greater in US premarket buying and selling on Friday after analysts ...
IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer By Investing.com
-- Research Meets General Response Price Major Endpoint, Encouraging Secondary Endpoint Development-Free Survival Information in Squamous Cell Carcinoma of the ...
July construction figures down but industry remains positive – Mortgage Strategy
Month-to-month development output is estimated to have decreased 0.4% in quantity phrases in July 2024; this follows a rise of ...
Stay positive on growth stocks and negative on value: Barclays By Investing.com
Barclays stays agency in its assist for development shares over worth, sustaining a constructive outlook on development throughout each the ...
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemo By Investing.com
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Confirmed Clinically Significant and Statistically Vital Profit: PFS Hazard Ratio of 0.46 For ...